Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03589339
Title NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nanobiotix
Indications

Advanced Solid Tumor

head and neck squamous cell carcinoma

Therapies

NBTXR3

NBTXR3 + unspecified PD-1 antibody

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.